David Roman
Stock Analyst at Goldman Sachs
(1.95)
# 3,165
Out of 5,113 analysts
61
Total ratings
37.14%
Success rate
-3.27%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDLN Medline | Initiates: Buy | $49 | $44.84 | +9.28% | 1 | Jan 12, 2026 | |
| HQY HealthEquity | Downgrades: Sell | $89 | $85.33 | +4.30% | 4 | Jan 9, 2026 | |
| KMTS Kestra Medical Technologies | Maintains: Neutral | $22 → $25 | $24.83 | +0.68% | 3 | Dec 15, 2025 | |
| COO The Cooper Companies | Maintains: Sell | $64 → $71 | $80.90 | -12.24% | 2 | Dec 8, 2025 | |
| MDT Medtronic | Upgrades: Neutral | $81 → $111 | $100.67 | +10.26% | 2 | Nov 19, 2025 | |
| IRTC iRhythm Holdings | Maintains: Neutral | $180 → $202 | $161.62 | +24.98% | 4 | Oct 31, 2025 | |
| EW Edwards Lifesciences | Maintains: Buy | $94 → $104 | $84.27 | +23.41% | 4 | Oct 31, 2025 | |
| BAX Baxter International | Maintains: Neutral | $25 → $22 | $19.65 | +11.96% | 4 | Oct 31, 2025 | |
| BBNX Beta Bionics | Maintains: Buy | $26 → $33 | $15.46 | +113.45% | 3 | Oct 29, 2025 | |
| BLCO Bausch + Lomb | Initiates: Neutral | $16 | $16.87 | -5.16% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $103 | $124.27 | -17.12% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $57 → $64 | $40.40 | +58.42% | 4 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $14.27 | +40.15% | 1 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $13.23 | +43.61% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $29 | $16.35 | +77.37% | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $380 | $271.31 | +40.06% | 1 | May 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $104 | $87.32 | +19.10% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $10 | $6.29 | +58.98% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $94 → $82 | $80.27 | +2.16% | 3 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $154 | $108.77 | +41.58% | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $24 | $20.20 | +18.81% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $63 → $71 | $79.01 | -10.14% | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $55 | $64.20 | -14.33% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $384 → $427 | $356.98 | +19.61% | 2 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $90 | $93.55 | -3.79% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $500 | $528.81 | -5.45% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $274 | $203.42 | +34.70% | 1 | May 30, 2024 |
Medline
Jan 12, 2026
Initiates: Buy
Price Target: $49
Current: $44.84
Upside: +9.28%
HealthEquity
Jan 9, 2026
Downgrades: Sell
Price Target: $89
Current: $85.33
Upside: +4.30%
Kestra Medical Technologies
Dec 15, 2025
Maintains: Neutral
Price Target: $22 → $25
Current: $24.83
Upside: +0.68%
The Cooper Companies
Dec 8, 2025
Maintains: Sell
Price Target: $64 → $71
Current: $80.90
Upside: -12.24%
Medtronic
Nov 19, 2025
Upgrades: Neutral
Price Target: $81 → $111
Current: $100.67
Upside: +10.26%
iRhythm Holdings
Oct 31, 2025
Maintains: Neutral
Price Target: $180 → $202
Current: $161.62
Upside: +24.98%
Edwards Lifesciences
Oct 31, 2025
Maintains: Buy
Price Target: $94 → $104
Current: $84.27
Upside: +23.41%
Baxter International
Oct 31, 2025
Maintains: Neutral
Price Target: $25 → $22
Current: $19.65
Upside: +11.96%
Beta Bionics
Oct 29, 2025
Maintains: Buy
Price Target: $26 → $33
Current: $15.46
Upside: +113.45%
Bausch + Lomb
Oct 1, 2025
Initiates: Neutral
Price Target: $16
Current: $16.87
Upside: -5.16%
Oct 1, 2025
Initiates: Buy
Price Target: $103
Current: $124.27
Upside: -17.12%
Oct 1, 2025
Downgrades: Sell
Price Target: $57 → $64
Current: $40.40
Upside: +58.42%
Aug 25, 2025
Initiates: Buy
Price Target: $20
Current: $14.27
Upside: +40.15%
Aug 18, 2025
Initiates: Buy
Price Target: $19
Current: $13.23
Upside: +43.61%
Jul 1, 2025
Initiates: Buy
Price Target: $29
Current: $16.35
Upside: +77.37%
May 30, 2025
Initiates: Buy
Price Target: $380
Current: $271.31
Upside: +40.06%
May 6, 2025
Maintains: Neutral
Price Target: $120 → $104
Current: $87.32
Upside: +19.10%
May 1, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $6.29
Upside: +58.98%
May 1, 2025
Maintains: Buy
Price Target: $94 → $82
Current: $80.27
Upside: +2.16%
Mar 4, 2025
Maintains: Buy
Price Target: $138 → $154
Current: $108.77
Upside: +41.58%
Mar 3, 2025
Maintains: Neutral
Price Target: $42 → $24
Current: $20.20
Upside: +18.81%
Mar 3, 2025
Maintains: Sell
Price Target: $63 → $71
Current: $79.01
Upside: -10.14%
Mar 3, 2025
Maintains: Buy
Price Target: $64 → $55
Current: $64.20
Upside: -14.33%
Jan 30, 2025
Maintains: Neutral
Price Target: $384 → $427
Current: $356.98
Upside: +19.61%
May 30, 2024
Initiates: Buy
Price Target: $90
Current: $93.55
Upside: -3.79%
May 30, 2024
Initiates: Buy
Price Target: $500
Current: $528.81
Upside: -5.45%
May 30, 2024
Initiates: Buy
Price Target: $274
Current: $203.42
Upside: +34.70%